On 2025-08-14, Actuate Therapeutics, Inc. (ACTU) announced earnings per share of $-0.30 for the fiscal quarter ending 2025-06-30, missing the average analyst estimate of $-0.19.
The next expected annoucement date for quarterly earnings is 2025-11-12, with an average estimated earnings per share of $-0.27 for the fiscal quarter ending 2025-09-30.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2025-08-14 | 2025-06-30 | $-0.19 | $-0.30 |
| 2025-05-15 | 2025-03-31 | $-0.26 | $-0.32 |
| 2024-11-13 | 2024-09-30 | -- | $-0.55 |
| 2024-09-24 | 2024-06-30 | -- | $-4.20 |
| 2024-07-23 | 2024-03-31 | -- | $-5.40 |